(MERS-CoV) is an emerging infectious disease that can present with flu-like symptoms. In individuals with comorbidities or who are immunosuppressed, it can be deadly. The disease is transmitted through contact with someone who has MERS-CoV. The occupational health nurse must be cognizant of and educate the workforce about MERS-CoV transmission, prevention, and treatment.
Transmission
The route of transmission from animals to humans is not yet clear. Strains of MERS-CoV that match human strains have been isolated from camels in Egypt, Oman, Qatar, and Saudi Arabia (WHO, 2015a) . Other animals such as goats, cows, water buffalo, sheep, and birds have been tested but no antibodies have been isolated in these animals. Currently, the consensus is that camels are likely the major reservoir host for MERS-CoV and an animal source of infection in humans (WHO, 2015a) .
The virus does not seem to pass easily from person to person unless in close contact, such as providing unprotected care to an infected patient or living with an infected individual (CDC, 2015f; WHO, 2015a) . The reported cases appear to be in clusters, such as in health care facilities, where human-tohuman transmission is more probable especially where infection control procedures are inadequate. As of June 7, 2015, no community-wide outbreak has been reported (WHO, 2015a).
Clinical Presentation
A wide clinical spectrum of MERS-CoV symptoms has been reported. Disease presentations range from asymptomatic infection to acute respiratory failure, septic shock, and multiorgan failure. A typical presentation of MERS-CoV disease is fever, cough, and shortness of breath. Symptoms may include chills/rigor, sore throat, headache, dizziness, non-productive cough, dyspnea, and myalgias. Some individuals reported (CDC, 2015d) . The median incubation period for secondary cases associated with humanto-human transmission is approximately 5 days with the range being from 2 to 14 days (CDC, 2015d) . Chest radiographic findings may include bilateral patchy densities, interstitial infiltrates, consolidation, and pleural effusions. Laboratory findings may include leukopenia, lymphopenia, thrombocytopenia, and elevated lactate dehydrogenase levels. Nosocomial bacterial and fungal infections have been reported in mechanically ventilated patients. MERS-CoV virus can be detected with a higher viral load and with longer duration in the lower versus upper respiratory tract. The virus has also been detected in feces, serum, and urine. Most state laboratories are approved to test for MERS-CoV using the CDC's real-time reverse transcription polymerase chain reaction (rRT-PCR) assay. At this time, very limited data are available on the duration and extrapulmonary MERS-CoV shedding (CDC, 2015d).
Identification of Individuals With MERS
The CDC (2015a) recommends that individuals should be evaluated for MERS-CoV if they present with the following: 
Prevention and Treatment of MERS-CoV
Currently, no vaccine is available to prevent MERS-CoV infection. According to the CDC (2015e), prevention includes actions that should be taken for any respiratory illness. These actions include washing hands with soap and water for 20 seconds or using an alcohol-based hand sanitizer if no water is available; covering mouth and nose with a tissue when coughing or sneezing; avoiding touching eyes, nose, and mouth with unwashed hands; avoiding personal contact such as kissing or sharing cups or eating utensils; and cleaning and disinfecting frequently touched surfaces such as doorknobs.
As a general precaution, anyone visiting farms or other places where camels or other animals are present should wash their hands and use other appropriate hygiene procedures. Contact with sick animals should be avoided. Undercooked meat should not be eaten. Camel meat and camel milk can continue to be consumed after pasteurization, cooking, or other heat treatments that kill microbes. Individuals with diabetes, renal failure, or chronic lung disease or who are immunocompromised are considered at high risk for severe disease after MERS-CoV exposure and should take appropriate precautions to avoid contact with camels, eating undercooked camel meat, or being in contact with individuals exposed to MERS-CoV (WHO, 2015a) .
No specific antiviral treatment for MERS-CoV infection has been developed. Clinical management includes supportive treatment of complications based on the individual's clinical presentation (WHO, 2015a).
Role of Occupational Health Nurse
The primary responsibility of occupational health nurses during any emerging health issue is to stay informed on the latest information available. Guidelines for individual work practices are available from the CDC's MERS-CoV guidance website (http://www.cdc.gov/coronavirus/mers/interimguidance.html) and the WHO website (http://www.who.int/csr/ disease/coronavirus_infections/en/). Employees require education on the risk of transmission within the workforce. Clearly outlined procedures are needed to guide supervisors on when to refer workers to the occupational health nurse and ensure that sick leave policies are enforced so that ill workers stay home and later safely return to work. MERS-CoV has highlighted how global travel interconnects the world. Currently, the CDC (2015b) does not recommend that anyone change travel plans due to MERS-CoV because most instances of transmission have occurred during close contact (e.g., health care workers and those individuals living with or caring for a family member). Recommendations from the CDC (2015b) for travel to Saudi Arabia include updating vaccines and general hygienic procedures. If workers do travel, they should monitor themselves for acute illness and know where to seek treatment. The occupational health nurse also should update the worksite's emergency preparedness and response plan, and consult appropriate resources such as the CDC and WHO for up-to-date recommendations. The occupational health nurse should stay in touch with local and state health departments regarding the reporting of MERS-CoV cases. The occupational health nurse and other health care providers in the workplace should be medically cleared, fit-tested, and trained for respirator use. Personal protective equipment and other infection control supplies (e.g., hand sanitizers and facemasks) should be available for both health care providers and workers. Through continuous monitoring of information about MERS-CoV, its transmission, symptoms, prevention and treatment, and worker education, the occupational health nurse can decrease anxieties at the workplace.
Conclusion
MERS-CoV warrants continued attention, especially in light of the increased prevalence of international travel. Even though a pandemic is less likely with MERS-CoV infection due to its close person-to-person transmission, a high level of vigilance in those countries with a significant number of travelers to the Middle East (e.g., migrant workers residing in the Saudi Arabian peninsula) is warranted (CDC, 2015f) . The occupational health nurse has a responsibility to educate workers about the transmission, prevention, and treatment of this infectious disease. By monitoring MERS-CoV outbreaks, occupational health nurses can fulfill their responsibility for creating and maintaining healthy and safe workplaces.
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